Status:
COMPLETED
Reducing Hospital Readmissions in Patients With Depressive Symptoms
Lead Sponsor:
Boston Medical Center
Collaborating Sponsors:
Agency for Healthcare Research and Quality (AHRQ)
Conditions:
Depression
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Project Re-Engineered Discharge (Project RED) has previously demonstrated that patients who received the RED were 30% less likely than patients receiving usual care to access inpatient or emergency se...
Eligibility Criteria
Inclusion
- Over 18 years of age
- Admitted to any Boston Medical Center inpatient service or for observation
- Screen positive for depressive symptoms (Patient Health Questionnaire - 2 \>/= 3)
- Speaks English with health care providers
- Has access to a telephone
- Live in the Boston area and don't plan on leaving the Boston area for more than 2 weeks in the next 6 months
- Screen positive for depressive symptoms (PHQ -9 \>/= 10)
Exclusion
- Has plans for inpatient rehabilitation, nursing home, or other institutional settings after discharge.
- Suicidal precautions
- Sickle Cell Crisis (SCC)
- Alcohol and/or drug dependence
- Diagnosis of Bipolar Disorder, Schizophrenia or other Psychotic Disorder
- In police custody
Key Trial Info
Start Date :
February 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2018
Estimated Enrollment :
709 Patients enrolled
Trial Details
Trial ID
NCT01840826
Start Date
February 1 2013
End Date
February 1 2018
Last Update
March 7 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston Medical Center
Boston, Massachusetts, United States, 02118